Globus Medical Inc. Class A

46.01+1.09+2.43%Vol 1.13M1Y Perf -40.50%
Dec 1st, 2023 16:00 DELAYED
BID45.00 ASK47.02
Open44.74 Previous Close44.92
Pre-Market- After-Market45.00
 - -  -1.01 -2.20%
Target Price
75.60 
Analyst Rating
Moderate Buy 2.46
Potential %
64.31 
Finscreener Ranking
★★     45.90
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
★★+     48.24
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
★★★★★     67.36
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
7.16 
Earnings Rating
Sell
Market Cap6.34B 
Earnings Date
7th Nov 2023
Alpha-0.01 Standard Deviation0.09
Beta1.10 

Today's Price Range

44.4146.01

52W Range

43.3980.04

5 Year PE Ratio Range

21.8084.20

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-0.67%
1 Month
-0.60%
3 Months
-15.16%
6 Months
-17.52%
1 Year
-40.50%
3 Years
-22.66%
5 Years
-4.72%
10 Years
138.15%

TickerPriceChg.Chg.%
GMED46.011.09002.43
AAPL191.241.29000.68
GOOG133.32-0.6000-0.45
MSFT374.51-4.4000-1.16
XOM102.990.25000.24
WFC45.020.43000.96
JNJ158.383.72002.41
FB196.640.99000.51
GE122.500.70000.57
JPM156.840.76000.49
ProfitabilityValueIndustryS&P 500US Markets
74.50
20.10
26.90
20.20
18.72
RevenueValueIndustryS&P 500US Markets
748.35M
9.67
8.61
9.45
Earnings HistoryEstimateReportedSurprise %
Q03 20230.540.575.56
Q02 20230.600.635.00
Q01 20230.510.533.92
Q04 20220.550.597.27
Q03 20220.520.50-3.85
Q02 20220.540.563.70
Q01 20220.460.42-8.70
Q04 20210.480.492.08
Earnings Per EndEstimateRevision %Trend
12/2023 QR0.58-4.92Negative
12/2023 FY2.310.00-
3/2024 QR0.60-1.64Negative
12/2024 FY2.662.70Positive
Next Report Date-
Estimated EPS Next Report0.55
Estimates Count8
EPS Growth Next 5 Years %11.50
Volume Overview
Volume1.13M
Shares Outstanding137.79K
Shares Float133.52M
Trades Count15.34K
Dollar Volume51.33M
Avg. Volume1.19M
Avg. Weekly Volume802.81K
Avg. Monthly Volume1.11M
Avg. Quarterly Volume1.67M

Globus Medical Inc. Class A (NYSE: GMED) stock closed at 46.01 per share at the end of the most recent trading day (a 2.43% change compared to the prior day closing price) with a volume of 1.13M shares and market capitalization of 6.34B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 2200 people. Globus Medical Inc. Class A CEO is David M. Demski.

The one-year performance of Globus Medical Inc. Class A stock is -40.5%, while year-to-date (YTD) performance is -38.05%. GMED stock has a five-year performance of -4.72%. Its 52-week range is between 43.385 and 80.04, which gives GMED stock a 52-week price range ratio of 7.16%

Globus Medical Inc. Class A currently has a PE ratio of 47.80, a price-to-book (PB) ratio of 4.09, a price-to-sale (PS) ratio of 7.48, a price to cashflow ratio of 39.10, a PEG ratio of 4.16, a ROA of 8.63%, a ROC of 8.91% and a ROE of 9.64%. The company’s profit margin is 18.72%, its EBITDA margin is 26.90%, and its revenue ttm is $748.35 Million , which makes it $9.67 revenue per share.

Of the last four earnings reports from Globus Medical Inc. Class A, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.55 for the next earnings report. Globus Medical Inc. Class A’s next earnings report date is -.

The consensus rating of Wall Street analysts for Globus Medical Inc. Class A is Moderate Buy (2.46), with a target price of $75.6, which is +64.31% compared to the current price. The earnings rating for Globus Medical Inc. Class A stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Globus Medical Inc. Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Globus Medical Inc. Class A has a Neutral technical analysis rating based on Technical Indicators (ADX : 6.04, ATR14 : 1.26, CCI20 : -15.29, Chaikin Money Flow : -0.14, MACD : -0.86, Money Flow Index : 41.05, ROC : 5.07, RSI : 46.72, STOCH (14,3) : 76.61, STOCH RSI : 1.00, UO : 50.97, Williams %R : -23.39), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Globus Medical Inc. Class A in the last 12-months were: Ann D. Rhoads (Sold 0 shares of value $-94 425 ), Keith Pfeil (Sold 0 shares of value $-1 502 442 ), Keith W. Pfeil (Sold 0 shares of value $-1 502 442 ), Keith W. Pfeil (Sold 29 167 shares of value $2 262 425 ), Lemaitre Dan (Sold 0 shares of value $-199 020 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (30.77 %)
4 (30.77 %)
3 (21.43 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
8 (61.54 %)
8 (61.54 %)
10 (71.43 %)
Moderate Sell
1 (7.69 %)
1 (7.69 %)
1 (7.14 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.46
Moderate Buy
2.46
Hold
2.64

Globus Medical Inc. Class A

Globus Medical is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which includes medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which includes advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

CEO: David M. Demski

Telephone: +1 610 930-1800

Address: 2560 General Armistead Avenue, Audubon 19403, PA, US

Number of employees: 2 200

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%37%

Bearish Bullish

55%45%

Bearish Bullish

62%38%

 

TipRanks News for GMED


News

Stocktwits